CORONARY ANGIOPLASTY AND STENTING IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY
https://doi.org/10.20862/0042-4676-2014-0-3-20-23
Abstract
Multiple coronary artery atherosclerotic lesions are a major cause of ischemic cardiomyopathy. Myocardial revascularization in patients with ischemic cardiomyopathy in the presence of the viable myocardium and/or ischemic areas leads to improved central hemodynamic parameters and as a consequence to better quality of life and prognosis as a whole. The paper describes a clinical case of successful coronary artery angioplasty and stenting in a patient with ischemic cardiomyopathy. Following 8 months, there was a considerable improvement in the patient’s general condition, an increase in left ventricular ejection fraction, and a reduction in cardiac cavity sizes.
About the Authors
A. N. Samko
Russian Cardiology Research-and-Production Complex, Ministry of Health of the RF
Russian Federation
Russian Federation
MD, PhD, DSc, Professor, Head of the Department of Endovascular Diagnosis and Treatment
ul. Tret’ya Cherepkovskaya, 15a, Moscow, 121552
E. V. Merkulov
Russian Cardiology Research-and-Production Complex, Ministry of Health of the RF
Russian Federation
Russian Federation
MD, PhD, Researcher of the Department of Endovascular Diagnosis and Treatment
ul. Tret’ya Cherepkovskaya, 15a, Moscow, 121552
V. M. Mironov
Russian Cardiology Research-and-Production Complex, Ministry of Health of the RF
Russian Federation
Russian Federation
Cardiologist
ul. Tret’ya Cherepkovskaya, 15a, Moscow, 121552
D. N. Filatov
Russian Cardiology Research-and-Production Complex, Ministry of Health of the RF
Russian Federation
Russian Federation
Cardiologist
ul. Tret’ya Cherepkovskaya, 15a, Moscow, 121552
References
1. Richardson P., McKenna W., Bristow M. et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definitionand Classification of cardiomyopathies. Circulation. 1996; 93 (5): 841–2.
2. Kolh Ph., Danchin N., Di Mario C. Classification of cardiomyopathies. Eur. Heart J. 2008; 29 (2): 270–6.
3. Ferrari R., La Canno G., Giubbini R. et al. Hibernating myocardium in patients with coronary artery disease: identification and clinical importance. Cardiovasc. Drugs Thcr. 1992; 6: 287–93.
4. Schuiz R., Hcuscli G. Characterization of hibernating and stunned myocardium. Eur. Heart J. 1995; 16 (2): 19–25.
5. Baker D.W., Jones R., Hodges J. Management of heart failure, the role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA. 2004; 27 (2): 1528–34.
6. Allman K.C., Shaw L.J., Hachamovitch R. et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J. Am. Coll. Cardiol. 2002; 39: 1151–8.
7. Eagle K.A., Guyton R.A., Davidoff R. et al. ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery: а report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J. Am. Coll. Cardiol. 2004; 2: 214–311.
Review
For citations:
Samko A.N., Merkulov E.V., Mironov V.M., Filatov D.N. CORONARY ANGIOPLASTY AND STENTING IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY. Journal of radiology and nuclear medicine. 2014;(3):20-23. (In Russ.) https://doi.org/10.20862/0042-4676-2014-0-3-20-23
Views:
802
Email this article 